Anti-Infectives Summit
An Interview with Nachum Kaplan, Vice President of Microbiology at Affinium Pharmaceuticals
March 10 by Pharmaceuticals & Biotechnology EditorAn Interview with Nachum Kaplan, Vice President of Microbiology at Affinium Pharmaceuticals on bacterial fatty-acid synthesis as a target for AFN-1252: a novel and selective-spectrum antibiotic for th...